BioStem Technologies today announced, in partnership with Veterans Medical Distributors Inc., a Service-Disabled Veteran-Owned Small Business (SDVOSB), that it has been awarded a five-year Federal Supply Schedule (FSS) contract for its VENDAJE™ line of amnion membrane allografts, by the U.S. Department of Veterans Affairs (VA).
BioStem Life Sciences has signed a Master Service Agreement with a new customer to manufacture the customer’s amniotic membrane platform for the next two years
BioStem Technologies today announced that it expects to file its annual and quarterly reports for the years 2018, 2019 and 2020 to become current with OTC Markets in late 2020.
